Gelmon KA, Fasching PA, Couch FJ, Balmana J, et al. Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysis. Eur J Cancer 2021;152:68-77.
PMID: 34087573